Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AhR Pharmaceuticals
Madison, Wisconsin, United States
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
AhR Pharmaceuticals focused on developing ITE, a natural hormone acting as an agonist of the aryl hydrocarbon receptor (AHR), for cancer, obesity, and immune system disorders. The company’s lead program remained in preclinical development with promising early proof-of-concept data but did not advance to clinical trials before becoming inactive.
- Therapeutic areas
- OncologyEndocrinologyImmunology
- Modalities
- Small molecule drug
- Industry
- Biotech
02
Partnerships
Wisconsin Alumni Research Foundation (WARF) – exclusive license for ITE intellectual property
Beyond the preview
Go deeper on AhR Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AhR Pharmaceuticals.